Targeting Amyloid and Tau: Current and Emerging Therapies

The pathological accumulation of amyloid-beta plaques and tau tangles remains a hallmark of Alzheimer’s disease. This session will explore current therapies targeting amyloid and tau, as well as novel strategies in development. The discussion will cover FDA-approved drugs, such as anti-amyloid monoclonal antibodies, and new clinical trial results from drugs aiming to halt or reverse tau pathology. By addressing these core pathologies, this track will focus on how therapeutic interventions may modify disease progression.
 

    Related Conference of Targeting Amyloid and Tau: Current and Emerging Therapies

    September 23-24, 2026

    6th Annual Congress on Mental Health

    Amsterdam, Netherlands
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France
    October 26-27, 2026

    6th Annual Psychiatrists and Psychologists Meet

    Amsterdam, Netherlands
    October 26-27, 2026

    International Congress on Cognitive Psychotherapy

    Amsterdam, Netherlands
    January 28-29, 2027

    9th International Congress on Mental Health

    Singapore City, Singapore
    March 18-19, 2027

    34th World Psychiatrists and Psychologists Meet

    Berlin, Germany
    March 25-26, 2027

    8th Annual Congress on Psychiatry

    Paris, France
    May 19-20, 2027

    9th European Autism Congress

    Paris, France
    September 14-15, 2027

    5th World Congress on Psychiatry

    London, UK

    Targeting Amyloid and Tau: Current and Emerging Therapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in